Skip to main content

Table 2 Univariate analysis of progression-free survival with selected factors

From: Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients

Variable Median progression-free survival (months) Univariate analysis (P value)
IL-6 (pg/ml)   
   < 2662 24  
   ≥ 2662 14 0.021
Stade   
   I 36  
   IV 14 0.009
Serum CA125 (U/ml)   
   < 319 29  
   > 319 14 0.040
Residual tumor   
   ≤ 2 cm 20  
   > 2 cm 11 0.076